{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:12:47Z","timestamp":1794892367888,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2210363"],"award-info":[{"award-number":["W81XWH2210363"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA244667"],"award-info":[{"award-number":["R01CA244667"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>BPTF, the scaffolding subunit of the nucleosome remodeling factor (NURF) complex, has been implicated in the progression of several malignancies, but its role in prostate cancer (PCa) remains unclear. Here, we demonstrate that BPTF is upregulated in castration-resistant prostate cancer (CRPC) and promotes disease progression. RNA-seq revealed that BPTF primarily enhances the expression of androgen receptor (AR) target genes. ChIP-seq showed that BPTF increases AR binding at promoters, enhancers and super-enhancers. ATAC-seq further demonstrated that BPTF increases chromatin accessibility to facilitate AR binding, in part through SMARCA1, a catalytic subunit of the NURF complex. Notably, BPTF\/AR co-bound regions are highly enriched for FOXA1 motifs but only weakly enriched for AR motifs. We further show that BPTF forms a protein complex with AR and FOXA1, in which FOXA1 recruits the BPTF-AR complex to chromatin, while BPTF stabilizes the AR-FOXA1 interaction. Importantly, BPTF interacts with AR through its bromodomain, and a BPTF bromodomain inhibitor disrupts this interaction, impairs AR signaling and suppresses PCa cell growth. In summary, our findings establish BPTF as a critical regulator of AR activity by promoting chromatin accessibility and stabilizing the AR-FOXA1 complex, highlighting BPTF as a potential therapeutic target in prostate cancer.<\/jats:p>","DOI":"10.1038\/s41467-025-67329-9","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T09:46:55Z","timestamp":1765446415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["BPTF regulates androgen receptor activity by enhancing chromatin accessibility and stabilizing the AR-FOXA1 interaction"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2168-7094","authenticated-orcid":false,"given":"Hee-Young","family":"Jeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0610-7745","authenticated-orcid":false,"given":"Sudeep","family":"Khadka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Pornour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunju","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hegang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8921-6091","authenticated-orcid":false,"given":"Hung-Ming","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9244-3807","authenticated-orcid":false,"given":"Eva","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8514-2713","authenticated-orcid":false,"given":"Htoo Zarni","family":"Oo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gleave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9087-1007","authenticated-orcid":false,"given":"Xiaofang","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0381-1947","authenticated-orcid":false,"given":"Christopher","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7884-7656","authenticated-orcid":false,"given":"Jianfei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"67329_CR1","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1038\/onc.2013.235","volume":"33","author":"X Yuan","year":"2014","unstructured":"Yuan, X. et al. Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis. Oncogene 33, 2815\u20132825 (2014).","journal-title":"Oncogene"},{"key":"67329_CR2","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","volume":"364","author":"JS de Bono","year":"2011","unstructured":"de Bono, J. S. et al. Abiraterone and increased survival in metastatic prostate cancer. N. Engl. J. Med. 364, 1995\u20132005 (2011).","journal-title":"N. Engl. J. Med."},{"key":"67329_CR3","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","volume":"367","author":"HI Scher","year":"2012","unstructured":"Scher, H. I. et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. N. Engl. J. Med. 367, 1187\u20131197 (2012).","journal-title":"N. Engl. J. Med."},{"key":"67329_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41585-021-00438-4","volume":"18","author":"KT Schmidt","year":"2021","unstructured":"Schmidt, K. T., Huitema, A. D. R., Chau, C. H. & Figg, W. D. Resistance to second-generation androgen receptor antagonists in prostate cancer. Nat. Rev. Urol. 18, 209\u2013226 (2021).","journal-title":"Nat. Rev. Urol."},{"key":"67329_CR5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc4016","volume":"15","author":"PA Watson","year":"2015","unstructured":"Watson, P. A., Arora, V. K. & Sawyers, C. L. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat. Rev. Cancer 15, 701\u2013711 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"67329_CR6","doi-asserted-by":"publisher","first-page":"e1000241","DOI":"10.1371\/journal.pgen.1000241","volume":"4","author":"J Landry","year":"2008","unstructured":"Landry, J. et al. Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells. PLoS Genet. 4, e1000241 (2008).","journal-title":"PLoS Genet."},{"key":"67329_CR7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.cell.2011.03.053","volume":"145","author":"AJ Ruthenburg","year":"2011","unstructured":"Ruthenburg, A. J. et al. Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions. Cell 145, 692\u2013706 (2011).","journal-title":"Cell"},{"key":"67329_CR8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s13046-021-02151-x","volume":"40","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. The emerging role of ISWI chromatin remodeling complexes in cancer. J. Exp. Clin. Cancer Res. 40, 346 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"67329_CR9","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0092-8674(00)80796-5","volume":"97","author":"A Hamiche","year":"1999","unstructured":"Hamiche, A., Sandaltzopoulos, R., Gdula, D. A. & Wu, C. ATP-dependent histone octamer sliding mediated by the chromatin remodeling complex NURF. Cell 97, 833\u2013842 (1999).","journal-title":"Cell"},{"key":"67329_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10153","volume":"7","author":"L Richart","year":"2016","unstructured":"Richart, L. et al. BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis. Nat. Commun. 7, 10153 (2016).","journal-title":"Nat. Commun."},{"key":"67329_CR11","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1038\/s41388-019-1125-7","volume":"39","author":"AL Green","year":"2020","unstructured":"Green, A. L. et al. BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway. Oncogene 39, 2305\u20132327 (2020).","journal-title":"Oncogene"},{"key":"67329_CR12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/carcin\/bgy144","volume":"40","author":"W Zhan","year":"2019","unstructured":"Zhan, W. et al. circCTIC1 promotes the self-renewal of colon TICs through BPTF-dependent c-Myc expression. Carcinogenesis 40, 560\u2013568 (2019).","journal-title":"Carcinogenesis"},{"key":"67329_CR13","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1038\/s41388-020-1331-3","volume":"39","author":"L Richart","year":"2020","unstructured":"Richart, L. et al. Bptf determines oncogenic addiction in aggressive B-cell lymphomas. Oncogene 39, 4884\u20134895 (2020).","journal-title":"Oncogene"},{"key":"67329_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11020-3","volume":"10","author":"E Koedoot","year":"2019","unstructured":"Koedoot, E. et al. Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes. Nat. Commun. 10, 2983 (2019).","journal-title":"Nat. Commun."},{"key":"67329_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41418-019-0333-6","volume":"27","author":"P Laurette","year":"2020","unstructured":"Laurette, P. et al. Chromatin remodellers Brg1 and Bptf are required for normal gene expression and progression of oncogenic Braf-driven mouse melanoma. Cell Death Differ. 27, 29\u201343 (2020).","journal-title":"Cell Death Differ."},{"key":"67329_CR16","doi-asserted-by":"publisher","first-page":"33878","DOI":"10.18632\/oncotarget.5302","volume":"6","author":"M Dai","year":"2015","unstructured":"Dai, M. et al. BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas. Oncotarget 6, 33878\u201333892 (2015).","journal-title":"Oncotarget"},{"key":"67329_CR17","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.7150\/thno.55424","volume":"11","author":"C Zhang","year":"2021","unstructured":"Zhang, C. et al. Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma. Theranostics 11, 3676\u20133693 (2021).","journal-title":"Theranostics"},{"key":"67329_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303091","volume":"10","author":"F Li","year":"2023","unstructured":"Li, F. et al. BPTF drives gastric cancer resistance to EGFR inhibitor by epigenetically regulating the C-MYC\/PLCG1\/perk axis. Adv. Sci. 10, e2303091 (2023).","journal-title":"Adv. Sci."},{"key":"67329_CR19","doi-asserted-by":"crossref","unstructured":"Munoz Velasco, R. et al. Targeting BPTF sensitizes pancreatic ductal adenocarcinoma to chemotherapy by repressing ABC-transporters and impairing multidrug resistance (MDR). Cancers 14, 1518 (2022).","DOI":"10.3390\/cancers14061518"},{"key":"67329_CR20","doi-asserted-by":"publisher","unstructured":"Felipe, I. et al. BPTF cooperates with MYCN and MYC to link neuroblastoma cell cycle control to epigenetic cellular states. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.02.11.579816 (2024).","DOI":"10.1101\/2024.02.11.579816"},{"key":"67329_CR21","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2023114221","volume":"42","author":"A Radzisheuskaya","year":"2023","unstructured":"Radzisheuskaya, A. et al. An alternative NURF complex sustains acute myeloid leukemia by regulating the accessibility of insulator regions. EMBO J. 42, e114221 (2023).","journal-title":"EMBO J."},{"key":"67329_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102418","volume":"55","author":"P Guo","year":"2022","unstructured":"Guo, P. et al. BPTF inhibition antagonizes colorectal cancer progression by transcriptionally inactivating Cdc25A. Redox Biol. 55, 102418 (2022).","journal-title":"Redox Biol."},{"key":"67329_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7445","volume":"13","author":"M Noura","year":"2024","unstructured":"Noura, M. et al. NUP98-BPTF promotes oncogenic transformation through PIM1 upregulation. Cancer Med. 13, e7445 (2024).","journal-title":"Cancer Med."},{"key":"67329_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nmeth.3871","volume":"13","author":"A Chavez","year":"2016","unstructured":"Chavez, A. et al. Comparison of Cas9 activators in multiple species. Nat. Methods 13, 563\u2013567 (2016).","journal-title":"Nat. Methods"},{"key":"67329_CR25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2403331121","volume":"121","author":"M Pornour","year":"2024","unstructured":"Pornour, M. et al. USP11 promotes prostate cancer progression by up-regulating AR and c-Myc activity. Proc. Natl. Acad. Sci. USA 121, e2403331121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67329_CR26","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1038\/onc.2015.309","volume":"35","author":"L Fan","year":"2016","unstructured":"Fan, L. et al. Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival. Oncogene 35, 2441\u20132452 (2016).","journal-title":"Oncogene"},{"key":"67329_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1535-6108(03)00197-1","volume":"4","author":"K Ellwood-Yen","year":"2003","unstructured":"Ellwood-Yen, K. et al. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4, 223\u2013238 (2003).","journal-title":"Cancer Cell"},{"key":"67329_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37544-3","volume":"14","author":"Z Wei","year":"2023","unstructured":"Wei, Z. et al. MYC reshapes CTCF-mediated chromatin architecture in prostate cancer. Nat. Commun. 14, 1787 (2023).","journal-title":"Nat. Commun."},{"key":"67329_CR29","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1038\/nprot.2013.150","volume":"8","author":"S Wang","year":"2013","unstructured":"Wang, S. et al. Target analysis by integration of transcriptome and ChIP-seq data with BETA. Nat. Protoc. 8, 2502\u20132515 (2013).","journal-title":"Nat. Protoc."},{"key":"67329_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WA Whyte","year":"2013","unstructured":"Whyte, W. A. et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307\u2013319 (2013).","journal-title":"Cell"},{"key":"67329_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Loven","year":"2013","unstructured":"Loven, J. et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153, 320\u2013334 (2013).","journal-title":"Cell"},{"key":"67329_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18035-1","volume":"11","author":"M Bentsen","year":"2020","unstructured":"Bentsen, M. et al. ATAC-seq footprinting unravels kinetics of transcription factor binding during zygotic genome activation. Nat. Commun. 11, 4267 (2020).","journal-title":"Nat. Commun."},{"key":"67329_CR33","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1016\/j.molcel.2024.06.029","volume":"84","author":"K Morse","year":"2024","unstructured":"Morse, K., Bishop, A. L., Swerdlow, S., Leslie, J. M. & Unal, E. Swi\/Snf chromatin remodeling regulates transcriptional interference and gene repression. Mol. Cell 84, 3080\u20133097 e3089 (2024).","journal-title":"Mol. Cell"},{"key":"67329_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0092-8674(00)81217-9","volume":"94","author":"G Schnitzler","year":"1998","unstructured":"Schnitzler, G., Sif, S. & Kingston, R. E. Human SWI\/SNF interconverts a nucleosome between its base state and a stable remodeled state. Cell 94, 17\u201327 (1998).","journal-title":"Cell"},{"key":"67329_CR35","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(00)81641-4","volume":"95","author":"FC Holstege","year":"1998","unstructured":"Holstege, F. C. et al. Dissecting the regulatory circuitry of a eukaryotic genome. Cell 95, 717\u2013728 (1998).","journal-title":"Cell"},{"key":"67329_CR36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0092-8674(00)81530-5","volume":"99","author":"JK Tyler","year":"1999","unstructured":"Tyler, J. K. & Kadonaga, J. T. The \u201cdark side\u201d of chromatin remodeling: repressive effects on transcription. Cell 99, 443\u2013446 (1999).","journal-title":"Cell"},{"key":"67329_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4972","volume":"5","author":"HJ Jin","year":"2014","unstructured":"Jin, H. J., Zhao, J. C., Wu, L., Kim, J. & Yu, J. Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program. Nat. Commun. 5, 3972 (2014).","journal-title":"Nat. Commun."},{"key":"67329_CR38","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1038\/emboj.2011.328","volume":"30","author":"B Sahu","year":"2011","unstructured":"Sahu, B. et al. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. EMBO J. 30, 3962\u20133976 (2011).","journal-title":"EMBO J."},{"key":"67329_CR39","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1039\/C8OB02599A","volume":"17","author":"SE Kirberger","year":"2019","unstructured":"Kirberger, S. E. et al. Selectivity, ligand deconstruction, and cellular activity analysis of a BPTF bromodomain inhibitor. Org. Biomol. Chem. 17, 2020\u20132027 (2019).","journal-title":"Org. Biomol. Chem."},{"key":"67329_CR40","doi-asserted-by":"crossref","unstructured":"Sinanian, M. M. et al. A BPTF inhibitor that interferes with the multidrug resistance pump to sensitize murine triple-negative breast cancer cells to chemotherapy. Int. J. Mol. Sci. 25, 11346 (2024).","DOI":"10.3390\/ijms252111346"},{"key":"67329_CR41","doi-asserted-by":"publisher","first-page":"8112","DOI":"10.1093\/nar\/gkw472","volume":"44","author":"S Sun","year":"2016","unstructured":"Sun, S. et al. BAP18 coactivates androgen receptor action and promotes prostate cancer progression. Nucleic Acids Res. 44, 8112\u20138128 (2016).","journal-title":"Nucleic Acids Res."},{"key":"67329_CR42","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s41418-023-01135-y","volume":"30","author":"G Sun","year":"2023","unstructured":"Sun, G. et al. BAP18 facilitates CTCF-mediated chromatin accessible to regulate enhancer activity in breast cancer. Cell Death Differ. 30, 1260\u20131278 (2023).","journal-title":"Cell Death Differ."},{"key":"67329_CR43","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1210\/me.2003-0020","volume":"17","author":"N Gao","year":"2003","unstructured":"Gao, N. et al. The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes. Mol. Endocrinol. 17, 1484\u20131507 (2003).","journal-title":"Mol. Endocrinol."},{"key":"67329_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1196\/annals.1336.009","volume":"1061","author":"X Yu","year":"2005","unstructured":"Yu, X. et al. Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially. Ann. N. Y Acad. Sci. 1061, 77\u201393 (2005).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"67329_CR45","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ccr.2013.02.016","volume":"23","author":"J Qi","year":"2013","unstructured":"Qi, J. et al. The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity. Cancer Cell 23, 332\u2013346 (2013).","journal-title":"Cancer Cell"},{"key":"67329_CR46","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1158\/0008-5472.CAN-20-0233","volume":"80","author":"S Xu","year":"2020","unstructured":"Xu, S. et al. p300-mediated acetylation of histone demethylase JMJD1A prevents its degradation by ubiquitin ligase STUB1 and enhances its activity in prostate cancer. Cancer Res. 80, 3074\u20133087 (2020).","journal-title":"Cancer Res."},{"key":"67329_CR47","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nprot.2016.020","volume":"11","author":"H Mohammed","year":"2016","unstructured":"Mohammed, H. et al. Rapid immunoprecipitation mass spectrometry of endogenous proteins (RIME) for analysis of chromatin complexes. Nat. Protoc. 11, 316\u2013326 (2016).","journal-title":"Nat. Protoc."},{"key":"67329_CR48","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1093\/nar\/gkad043","volume":"51","author":"HY Jeon","year":"2023","unstructured":"Jeon, H. Y. et al. SMAD3 promotes expression and activity of the androgen receptor in prostate cancer. Nucleic Acids Res. 51, 2655\u20132670 (2023).","journal-title":"Nucleic Acids Res."},{"key":"67329_CR49","doi-asserted-by":"publisher","first-page":"21 29 21","DOI":"10.1002\/0471142727.mb2129s109","volume":"109","author":"JD Buenrostro","year":"2015","unstructured":"Buenrostro, J. D., Wu, B., Chang, H. Y. & Greenleaf, W. J. ATAC-seq: a method for assaying chromatin accessibility genome-wide. Curr. Protoc. Mol. Biol. 109, 21 29 21\u201321 29 29 (2015).","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"67329_CR50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ccr.2006.09.005","volume":"10","author":"H Hieronymus","year":"2006","unstructured":"Hieronymus, H. et al. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell 10, 321\u2013330 (2006).","journal-title":"Cancer Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67329-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67329-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67329-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T21:02:56Z","timestamp":1769288576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67329-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67329"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67329-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"670"}}